GILD and partner MRK advance novel investigational combination regimen, a weekly oral HIV treatment, to phase III.

The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

PASIGHAT, 17 Oct: “One should not lose sight of the goal to eliminate HIV/AIDS; it is time to create awareness among the people and break the chain of infection,” said Pasighat East MLA Tapi Darang ...

Still, you might need a secondary form of protection if you ... Centers for Disease Control and Prevention. About HIV. HIV.gov. The stages of HIV infection. HIV.gov. HIV and AIDS: The basics.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752) ...

The University of Manitoba has been the beneficiary of almost half-a-billion dollars in grants — the most of any ...

The rise in teenage pregnancies in South Africa underscores the challenges faced by adolescent mothers and the gaps in sexual and reproductive health services.

Primary healthcare that seeks to promote early screenings, disease prevention and a healthy lifestyle should be emphasised in ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

African women die of breast cancer within five years in four out of five cases, compared to early diagnosis in developed ...

In June, Ntlati convicted Conga of rape, because Ndishishi only consented to having sex with him on the understanding that he was HIV-negative ... Many women suffer such secondary victimisation ...